Literature DB >> 24319005

T-cell Ig and ITIM domain regulates natural killer cell activation in murine acute viral hepatitis.

Jiacheng Bi1, Qing Zhang, Dan Liang, Lei Xiong, Haiming Wei, Rui Sun, Zhigang Tian.   

Abstract

UNLABELLED: Uncontrolled natural killer (NK) cell activation during the early response to acute viral infection can lead to severe immunopathology, and the mechanisms NK cells use to achieve self-tolerance in such contexts are currently unclear. Here, NK cells up-regulated a coinhibitory receptor, T-cell Ig and ITIM domain (TIGIT), during challenge with the viral double-stranded RNA (dsRNA) analog poly I:C. Blocking TIGIT by antibody treatment in vivo or a genetic deficiency in Tigit enhanced NK cell activation and aggravated liver injury in a poly I:C/D-GalN-induced model of acute fulminant hepatitis, suggesting that TIGIT is normally required for protecting against NK cell-mediated liver injury. Furthermore, adoptively transferring Tigit(-/-) NK cells into NK cell-deficient Nfil3(-/-) mice also resulted in elevated liver injury. Reconstituting Kupffer cell-depleted mice with poliovirus receptor (PVR/CD155, a TIGIT ligand)-silenced Kupffer cells led to aggravated liver injury in a TIGIT-dependent manner. Blocking TIGIT in an NK-Kupffer cell coculture in vitro enhanced NK cell activation and interferon-gamma (IFN-γ) production in a PVR-dependent manner. We also found that TIGIT was up-regulated selectively on NK cells and protected against liver injury in an acute adenovirus infection model in both an NK cell- and Kupffer cell-dependent manner. Knocking down PVR in Kupffer cells resulted in aggravated liver injury in response to adenovirus infection in a TIGIT-dependent manner.
CONCLUSION: TIGIT negatively regulates NK-Kupffer cell crosstalk and alleviates liver injury in response to poly I:C/D-GalN challenge or acute adenovirus infection, suggesting a novel mechanism of NK cell self-tolerance in liver homeostasis during acute viral infection.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24319005     DOI: 10.1002/hep.26968

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

1.  T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signaling.

Authors:  Man Li; Pengyan Xia; Ying Du; Shengwu Liu; Guanling Huang; Jun Chen; Honglian Zhang; Ning Hou; Xuan Cheng; Luyu Zhou; Peifeng Li; Xiao Yang; Zusen Fan
Journal:  J Biol Chem       Date:  2014-05-09       Impact factor: 5.157

Review 2.  Tim-3, Lag-3, and TIGIT.

Authors:  Nicole Joller; Vijay K Kuchroo
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

3.  Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice.

Authors:  Takuro Uchida; Nobuhiko Hiraga; Michio Imamura; Masataka Tsuge; Hiromi Abe; C Nelson Hayes; Hiroshi Aikata; Yuji Ishida; Chise Tateno; Katsutoshi Yoshizato; Hideki Ohdan; Kazunari Murakami; Kazuaki Chayama
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

Review 4.  Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.

Authors:  Cheng Sun; Hao-yu Sun; Wei-hua Xiao; Cai Zhang; Zhi-gang Tian
Journal:  Acta Pharmacol Sin       Date:  2015-06-15       Impact factor: 6.150

Review 5.  NK Cell Exhaustion.

Authors:  Jiacheng Bi; Zhigang Tian
Journal:  Front Immunol       Date:  2017-06-28       Impact factor: 7.561

Review 6.  TIGIT Blockade: A Multipronged Approach to Target the HIV Reservoir.

Authors:  Kayla A Holder; Michael D Grant
Journal:  Front Cell Infect Microbiol       Date:  2020-05-05       Impact factor: 5.293

Review 7.  Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma.

Authors:  Shaoping Shen; Ling Chen; Jialin Liu; Lin Yang; Mengna Zhang; Lingxiong Wang; Rong Zhang; Yasushi Uemura; Qiyan Wu; Xinguang Yu; Tianyi Liu
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

Review 8.  Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review.

Authors:  Faezeh Hosseinzadeh; Javad Verdi; Jafar Ai; Saieh Hajighasemlou; Iman Seyhoun; Frzad Parvizpour; Fatemeh Hosseinzadeh; Abolfazl Iranikhah; Sadegh Shirian
Journal:  Cancer Cell Int       Date:  2018-09-10       Impact factor: 5.722

Review 9.  NK cell education via nonclassical MHC and non-MHC ligands.

Authors:  Yuke He; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2016-06-06       Impact factor: 11.530

10.  Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals.

Authors:  Xiaowan Yin; Tingting Liu; Zhuo Wang; Meichen Ma; Jie Lei; Zining Zhang; Shuai Fu; Yajing Fu; Qinghai Hu; Haibo Ding; Xiaoxu Han; Junjie Xu; Hong Shang; Yongjun Jiang
Journal:  Front Immunol       Date:  2018-10-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.